Anti-inflammatory activity of 2,3-dihydrophthalazine-1,4-diones in CF1 mice

International Journal of Tissue Reactions

Volumn 18, Issue 2-3, 1996, Pages 47-55

  Butner, L ^a   Huang, Y ^a   Tse, E ^a   Hall, I H ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 1,4 PHTHALAZINEDIONE; ANTIINFLAMMATORY AGENT; CORTISONE; DEXAMETHASONE; FREE RADICAL; INDOMETACIN; INTERLEUKIN 1; LIPOXYGENASE; MORPHINE; PENTOXIFYLLINE; PHENYLBUTAZONE; PHOSPHATASE; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG SYNTHESIS; ENZYME ACTIVITY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PAIN;

EID: 0030425126     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Tse E., Butner L., Huang Y , Hall I.H The anti-inflammatory activity of N-substituted indazolones in mice Arch Pharm (Weinheim), 1996, (in press)
2. 1 mice Drug Investigation, 1996, (in press).
3. Hall I.H. et al The anti-inflammatory activity of 5H-dibenz [c,e]azepine-5,7(6H)dione, 6,7-dihydro-5H-dibenz[c,e]azepine, N-benzoylbenzamide and 1H-benz[d,e]isoquinoline-1,3(2H)dione in rodents Acta Pharm. Nord , 2, 387-400, 1990
4. Murthy A.R K , Hall I.H , Chapman J M. Jr , Rhyne K A , Wyrick S D Hypolipidemic activity of a series of 2,3-dihydrophthalazine-1,4-dione derivatives in rodents. Pharm. Res., 3, 93-101, 1986
5. Hall I H., Hall E.S , Wong O The anti-neoplastic activity of 2,3-dihydrophthalazine-1,4-dione and N-butyl-2,3-d:hydrophthalazine-1,4-dione in human and murine tumor cells J. Pharm Sci, 69, 1025-1029, 1992
6. Winter C A , Risley E , Nuss G Carrageenm-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc. Exp. Biol Med , 111, 544-547, 1962.
7. Roszkowski A P , Rooks W H., Tomonlonis A , Miller L.M Anti-inflammatory and analgesic properties of d-2-(6′-methyl-2′-naphthyl)propionic acid (naproxen). J. Pharm Exp. Ther., 179, 114-123, 1971
8. Noronha-Blob L , Löwe V.C , Westzberg M , Burch R M NPC 15669 enhances survival and reverses leukopenia in endotoxin treated mice. Eur J Pharm., 199, 387-388, 1991.
9. Hendershot L C., Forsaith J. Antagonists of the frequency of phenylquinone-induced writhing in the mouse by weak analgesic and non-analgesics J Pharmacol Exp Ther., 125, 237-240, 1959
10. Hall I.H., Hall J E , Jr., Mohseni M , Sajadi Z. Antiinflammatory activity of diazomethylketone and chloromethylketone analogs prepared from N-tosyl amino acids. J. Pharm. Sci, 69, 1451-1452, 1980
11. Hall I.H. et al The anti-inflammatory activity of metal complexes and salts of trimethylamine-carboxyboranes. Appl Org. Metal Chem., 8, 473-480, 1994
12. Hall I.H et al. Anti-inflammatory activity of amine-carboxyboranes in rodents. Arch Pharm. (Weinheim), 338, 39-44, 1995.
13. Kull F.C Jr The TNF receptor in TNF-mediated cytotoxicity. Nat. Immun. Cell Growth Regul., 7, 254-265, 1988.
14. Tomlinson RV, Ringold H J., Qureshi M.C , Forchieli E Relationship between inhibition of prostaglandin synthesis and drug efficacy. Support of the current theory on mode of action of aspirin-like drugs Biochem Biophys. Res Commun, 46, 552-559, 1972.
15. Glatt M , Kalin H., Wagner K , Brune K. Prostaglandin release from macrophages an assay system for anti-inflammatory drugs in vitro Agents Actions, 7, 321-326, 1977
16. Flynn D L. et al Styrypyrazoles, styrylisoxazoles, and styrylisothiazole Novel 5-lipoxygenase and cyclooxygenase inhibitors J Med Chem, 34, 518-525, 1991.
17. Chen P S , Toribara T Y , Warner H. Microdetermination of phosphorus. Anal. Chem , 28, 1756-1758, 1956.
18. 3 and parathyroid hormone stimulated calcium and lysosomal enzyme release from mouse calvaria in vitro. Agents Actions, 32, 321-332, 1977.
19. Kunchandy E A , Rao M N.A Effects of curcumin on hydroxyl radical generation through Fenton reaction Int. J Pharmaceutics, 57, 173-176, 1989.
20. Roch-Arveller M et al Effects of some non-steroid anti-inflammatory drug copper complexes on polymorphonuclear leukocyte oxidation metabolism Agents Actions, 31, 65-71, 1990.
21. Murphy M E. et al The relationship between cytokine regulation and anti-inflammatory action of amine-carboxyboranes in L929 fibroblasts and IC-21 macrophages. Metal-Based Drugs, 2, 257-269, 1995.
22. Murphy M.E. et al The effects of amine-carboxyborane related derivatives on UMR-106 bone metabolism. Metal-Based Drugs, 1996, (in press).
23. Hall I.H. et al. Anti-inflammatory activity of amine-carboxyboranes in rodents. Arch Pharm., 328, 39-44, 1995
24. 1 mice Res. Commun Pharm Toxic., 1, 17-38, 1996
25. Hall I.H., Chen S Y , Rajendran K.G., West D X The anti-inflammatory activity of metal complexes of thiosemicarbazones. Applied Organometallic Chem , 1996, (in press).
26. Beutler B "Tumor necrosis factor". Raven Press, New York, 1992, pp 87-96 and 255-274.
27. Larrick J W , Wright S C. Cytotoxic mechanisms of tumor necrosis factor-α. FASEB J., 4, 3215-3223, 1990.
28. Brouckaert P. et al Tumor necrosis factor, its receptor and the connection with interleukin 1 and interleukin 6. Immunobiol , 187, 317-329, 1993.
29. Cooper K., Masamune H Cytokine modulation as a medicinal chemistry target Annu. Rep. Med Chem , 27, 209-218, 1992.
30. Dingle J.T , Shield M.J The interaction of cytokines, NSAID, and prostaglandins in cartilage destruction and repair. Adv Prostaglandin, Thromboxane and Leukotriene Res , 21, 955-965, 1990.
31. Marshall P.J. et al Pharmacology of SK & F 105809-1 Biochem Pharmacol, 42, 813, 1992.
32. Batt G.R et al Substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis J Med. Chem., 36, 1434-1442, 1993
33. Otterness I G , Bliven M L , Downs J.T., Natoli E H , Hanson D C. Inhibition of interleukin 1 synthesis by Tenidap: a new drug for arthritis Cytokine, 3, 227, 1991
34. Brooks P.M Tenidap-a new anti-arthritic agent. Agents Actions, Suppl. 44, 161-163, 1993.
35. Dougados M. et al. IX-207-887 in rheumatoid arthritis A double-blind placebo-controlled study. Arthritis Rheum, 35, 999-1006, 1992
36. Folliard F, Bousseau A., Terlain B. RP-54745, a potential anti-rheumatic compound I. Agents Actions, 36, 119-126, 1992.